Teva Nefazodone Statement

Nefazodone is now available. Teva originally alerted the US FDA – and Wholesalers, Distributors and Pharmacies – in the summer of 2020 about a potential shortage of Nefazodone, and has been working diligently since that time in the interest of patients. We are pleased to now be able to once again provide Nefazodone as a viable option for those who need it. As always, patients should continue to speak with their physician about the treatment that is right for them.

Share this article: